Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Stoke Therapeutics, Inc. | 193,000 | reported | 17 Feb 2026 | tx 7+1,614,399 |
| Odyssey Therapeutics, Inc. | 27,393 | reported | 07 May 2026 | tx 1+27,393 |
| Foghorn Therapeutics Inc. | 25,000 | reported | 17 Jun 2025 | tx 7+137,567 |
| Ophthotech Corp. | 20,000 | reported | 02 Aug 2016 | tx 1+20,000 |
| ACORDA THERAPEUTICS INC | 15,000 | reported | 27 Jun 2018 | tx 31+191,462−96,462 |
| VERTEX PHARMACEUTICALS INC / MA | 10,625 | reported | 29 Jun 2018 | tx 341+3,248,562−3,366,700 |
| EPIX Pharmaceuticals, Inc. | 10,000 | reported | 16 Jun 2009 | tx 5+60,703 |
| DISCOVERY PARTNERS INTERNATIONAL INC | 4,000 | reported | 12 Jun 2018 | tx 25+266,720 |
| Solid Biosciences Inc. | 0 | reported | 06 Jan 2026 | tx 53+1,817,963−168,150 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | GRANT_AWARD | Odyssey Therapeutics, Inc. | 27,393 | 0.00 USD | deriv |
| 17 Feb 2026 | GRANT_AWARD | Stoke Therapeutics, Inc. | 193,000 | 0.00 USD | deriv |
| 17 Feb 2026 | GRANT_AWARD | Stoke Therapeutics, Inc. | 129,000 | 0.00 USD | deriv |
| 06 Jan 2026 | EXERCISE | Solid Biosciences Inc. | 4,573 | — | |
| 02 Jan 2026 | GRANT_AWARD | Solid Biosciences Inc. | 13,761 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Solid Biosciences Inc. | 18,012 | 0.00 USD | deriv |
| 06 Jan 2026 | EXERCISE | Solid Biosciences Inc. | 4,573 | 0.00 USD | deriv |
| 08 Oct 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 380,000 | 0.00 USD | deriv |
| 08 Oct 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 570,000 | 0.00 USD | deriv |
| 06 Oct 2025 | EXERCISE | Solid Biosciences Inc. | 4,573 | — | |
| 06 Oct 2025 | EXERCISE | Solid Biosciences Inc. | 4,573 | 0.00 USD | deriv |
| 06 Jul 2025 | EXERCISE | Solid Biosciences Inc. | 4,573 | — | |
| 06 Jul 2025 | EXERCISE | Solid Biosciences Inc. | 4,573 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Foghorn Therapeutics Inc. | 25,000 | 4.79 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Solid Biosciences Inc. | 77,500 | 0.00 USD | deriv |
| 06 Apr 2025 | EXERCISE | Solid Biosciences Inc. | 4,574 | — | |
| 06 Apr 2025 | EXERCISE | Solid Biosciences Inc. | 4,574 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 238,420 | 0.00 USD | deriv |
| 03 Jan 2025 | EXERCISE | Solid Biosciences Inc. | 3,255 | — | |
| 06 Jan 2025 | GRANT_AWARD | Solid Biosciences Inc. | 18,293 | 0.00 USD | deriv |
| 06 Jan 2025 | GRANT_AWARD | Solid Biosciences Inc. | 22,148 | 0.00 USD | deriv |
| 03 Jan 2025 | EXERCISE | Solid Biosciences Inc. | 3,255 | 0.00 USD | deriv |
| 03 Oct 2024 | EXERCISE | Solid Biosciences Inc. | 3,255 | — | |
| 03 Oct 2024 | EXERCISE | Solid Biosciences Inc. | 3,255 | 0.00 USD | deriv |
| 03 Jul 2024 | EXERCISE | Solid Biosciences Inc. | 3,255 | — |